Get the app
public
ios_share
Annals On Call Podcast
chevron_right
SGLT2 vs GLP1 for Cardiovascular Prevention
Dec 20, 2021
23:05
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Dr. Centor discusses the use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.
